Pittman PR, Kim-Ahn G, Pifat DY, Coon K, Gibbs P, Little S, Pace-Templeton J, Myers R, Parker GW, Friedlander AM. 2002. Anthrax vaccine: safety and immunogenicity of a dose-reduction, route comparison study in humans. Vaccine 20(9–10):1412–1420.

Plotkin SA, Brachman PS, Utell M, Bumford FH, Atchison MM. 1960. An epidemic of inhalation anthrax, the first in the twentieth century. American Journal of Medicine 29:992–1001.

Puziss M, Wright GG. 1963. Studies on immunity in anthrax. X. Gel adsorbed protective antigen for immunization of man. Journal of Bacteriology 85:230–236.

Rehme PA, Wiliams R, Grabenstein JD. 2002. Ambulatory medical visits among anthrax vaccinated and unvaccinated personnel after return from Southwest Asia. Military Medicine 167:205–210.

Roche KJ, Chang MW, Lazarus H. 2001. Cutaneous anthrax infection. New England Journal of Medicine 345(22):1611.

Shlyakhov EN, Rubinstein E. 1994. Human live anthrax vaccine in the former USSR. Vaccine 12(8):727–730.

Turnbull PC. 1991. Anthrax vaccines: past, present and future. Vaccine 9(8):533–539.

Turnbull PCB. 2000. Current status of immunization against anthrax: old vaccines may be here to stay for a while. Current Opinion in Infectious Diseases 13(2):113–120.

Wright GG, Puziss M. 1957. Elaboration of protective antigen of Bacillus anthracis under anaerobic conditions. Nature 179:916–917.

Wright GG, Hedberg MA, Slein JB. 1954. Studies on immunity in anthrax. III. Elaboration of protective antigen in a chemically-defined, non-protein medium. Journal of Immunology 72:263–269.

Wright GG, Puziss M, Neely WB. 1962. Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis . Journal of Immunology 83:515–522.

Zilinskas RA. 1997. Iraq’s biological weapons: the past as future? JAMA 278(5):418–424.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement